Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatostatin receptors.

N Benali1, G Ferjoux, E Puente

  • 1INSERM U 531, CHU Rangueil, Toulouse, France.

Digestion
|August 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study.

ESMO gastrointestinal oncology·2026
Same author

[Venous thromboembolism and pancreatic cancer].

Journal de medecine vasculaire·2018
Same author

The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.

Oncogene·2016
Same author

The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2014
Same author

Dual roles of hemidesmosomal proteins in the pancreatic epithelium: the phosphoinositide 3-kinase decides.

Oncogene·2013
Same author

Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2012
Same journal

Directional Bias in Polyp Detection during Colonoscopy: A Prospective Observational Study.

Digestion·2026
Same journal

Prospective validation of magnified endoscopic examination with image-enhanced endoscopy as an optical biopsy for differentiating superficial duodenal epithelial tumor and non-neoplastic lesion in duodenum.

Digestion·2026
Same journal

Accurate imaging diagnosis of small pancreatic carcinoma/high-grade pancreatic intraepithelial neoplasia using combined indirect imaging findings.

Digestion·2026
Same journal

Restoration of gut microbiota dysbiosis by a probiotic Lactobacillus paragasseri OLL2716 in patients being treated with low-dose aspirin and acid-suppressive agents.

Digestion·2026
Same journal

Adverse Events after Colorectal Polypectomy in Patients with Amyloidosis: Risk Assessment Using Propensity Score Matching.

Digestion·2026
Same journal

Prognostic effect of MES 1 inflammatory extent on remission maintenance in ulcerative colitis.

Digestion·2026
See all related articles

Somatostatin receptors (sst1-sst5) mediate somatostatin's effects on cellular functions. Selective synthetic analogues target sst2, sst5, and sst3 for neuroendocrine tumor treatment, with sst2 expression varying in cancers.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Somatostatin is a neuropeptide regulating diverse cellular functions like secretion, motility, and proliferation.
  • Its actions are mediated by five G protein-coupled receptors: somatostatin receptor subtypes 1-5 (sst1-sst5).
  • Synthetic somatostatin analogues are crucial in treating neuroendocrine tumors, primarily interacting with sst2, sst5, and sst3.

Purpose of the Study:

  • To elucidate the differential expression and functional roles of somatostatin receptor subtypes.
  • To understand the signaling pathways modulated by each receptor subtype.
  • To explore the therapeutic implications of somatostatin receptor targeting in various cancers.

Main Methods:

  • Analysis of somatostatin receptor subtype expression in normal and tumor cells.

Related Experiment Videos

  • Investigation of G protein-dependent and -independent signaling pathways.
  • Utilizing selective receptor agonists and genetically modified animal models.

    • Main Results:

    • Receptor subtype expression is cell-type and stimulus-specific.
    • sst2 is highly expressed in neuroendocrine tumors but lost in advanced pancreatic and colorectal carcinomas.
    • sst1, sst2, and sst5 inhibit Growth Hormone (GH) secretion; sst2 and sst5 inhibit glucagon and insulin secretion, respectively.

    Conclusions:

    • Somatostatin receptor subtype expression and function are critical in regulating endocrine secretions and cellular processes.
    • Differential expression patterns, particularly the loss of sst2 in advanced carcinomas, highlight the complexity of somatostatin signaling in disease.
    • Targeted therapies utilizing selective receptor agonists hold promise for treating conditions associated with altered somatostatin receptor activity.